Urogen Pharma Ltd URGN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:15 AM EDT
16.19quote price arrow up+0.15 (+0.94%)
Volume
20,608
52 week range
14.19 - 28.20
Loading...
  • Open16.13
  • Day High16.27
  • Day Low15.98
  • Prev Close16.04
  • 52 Week High28.20
  • 52 Week High Date02/11/21
  • 52 Week Low14.19
  • 52 Week Low Date08/20/21

Key Stats

  • Market Cap362.01M
  • Shares Out22.36M
  • 10 Day Average Volume0.08M
  • Dividend-
  • Dividend Yield-
  • Beta1.22
  • YTD % Change-11.15

KEY STATS

  • Open16.13
  • Day High16.27
  • Day Low15.98
  • Prev Close16.04
  • 52 Week High28.20
  • 52 Week High Date02/11/21
  • 52 Week Low14.19
  • 52 Week Low Date08/20/21
  • Market Cap362.01M
  • Shares Out22.36M
  • 10 Day Average Volume0.08M
  • Dividend-
  • Dividend Yield-
  • Beta1.22
  • YTD % Change-11.15

RATIOS/PROFITABILITY

  • EPS (TTM)-5.02
  • P/E (TTM)-3.22
  • Fwd P/E (NTM)-3.34
  • EBITDA (MRQ)-104.667M
  • ROE (MRQ)-112.10%
  • Revenue (MRQ)31.94M
  • Gross Margin (MRQ)89.72%
  • Net Margin (MRQ)-349.05%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Urogen Pharma Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
UroGen Pharma Ltd. Is an Israel-based biopharmaceutical company. The Company is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel are formulated using its proprietary reverse thermally triggered hydrogel, or...
Arie Belldegrun M.D.
Non-Executive Chairman
Elizabeth Barrett
President
Molly Henderson CPA
Chief Financial Officer
Address
9 Ha'ta'asiya St
Ra'anana
4365007
Israel

Top Peers

SYMBOLLASTCHG%CHG
KMPH
KemPharm Inc
9.04+0.10+1.13%
MTEM
Molecular Templates Inc
6.01-0.19-3.06%
FIXX
Homology Medicines Inc
8.15+0.25+3.10%
XOMA
XOMA Corp
24.11-0.19-0.78%
PIRS
Pieris Pharmaceuticals Inc
5.70-0.06-1.04%